eLetters

534 e-Letters

published between 2003 and 2006

  • Author's reply
    Suna Emir

    Dear Editor

    We thank Dr Biban for his comments on our article.[1] We share his concerns that our case has some interesting and unique points. As he/she stated that our case was the first reported case of a Kasabach-Merrit syndrome (KSM) associated with a lipomatous tumor. Her severe findings due to KSM and as well as her progressively enlarging mass on the shoulder were dramatically responded to interferon therapy.[...

    Show More
  • CT radiation doses
    Kieran McHugh

    Dear Editor

    The hazards of computed tomography (CT), in terms of radiation, are being increasingly recognized. CT scanning, despite representing less than 5% of the total number of X-ray procedures performed, contributes approximately 40% of the total collective radiation dose to the UK population from all medical X-ray examinations.[1] It is well known that children are more radiosensitive than adults e.g. a 1-yea...

    Show More
  • Assessing Immune responses to pneumococcal vaccines
    Raman Lakshman

    Dear Editor

    The recent article and letter [1,2] discussing recommendations for use of heptavalent pneumococcal conjugate vaccine (Prevenar) for at risk children is timely and interesting. We concur with the authors that further immunogenicity studies are necessary in various high-risk groups to demonstrate the best protective schedule.

    Children older than 2 years with recurrent infections and normal humor...

    Show More
  • Lung function and low birth weight
    Michael Silverman

    Dear Editor

    At the risk of being accused of raising a trivial issue, I would simply like to ask authors to quote accurately from references within their articles. I am concerned in particular about the study of the respiratory outcome of children of very low birthweight reported recently by Anand and colleagues.[1] They quote the results of a similar study of younger children, which we reported some years ago in...

    Show More
  • Kawasaki Disease. Unknown outcome of long term follow-up.
    Robert Tulloh

    Dear Editor

    We would like to reply to the letter by Murugan [1] following our article on Kawasaki disease.[2] We have suggested that children with known Kawasaki disease and normal coronary arteries should have lifelong follow-up. The long term vascular damage from Kawasaki Disease is uncertain, but evidence from Dhillon et al suggests that abnormalities of systemic endothelial function are present many years after...

    Show More
  • Response to Dr Srinivas S Gada
    Sarah Stewart-Brown

    Dear Editor,

    Universal versus high risk approaches to parenting education and support

    Drs Srinivas, Gada, Shanker and Kanumaka make a number of useful points about our trial.

    First, they query our response rate. This rate can be calculated using either the number of families or the number of children as the denominator. The rate we quoted 800/1155 is the proportion of families responding. T...

    Show More
  • Letter to the editor (Commenting on a commentary ...)
    Maximilian S. Zach

    Dear Editor

    Our recently published article on partial splenectomy in cystic fibrosis (CF) patients with hypersplenism [1] appeared with a commentary by colleagues from the Birmingham Children’s Hospital.[2] While we appreciate the attention that our article received, we also believe that we have to comment on some of the statements in this commentary.

    The authors of this commentary rightfully point out that...

    Show More
  • Changes in serum sodium levels during treatment of hyperglycaemia
    Anne Marie Oudesluys-Murphy

    Dear Editor

    We read the paper by Carlotti et al. [1] with great interest.

    They state that fluid and electrolyte management might contribute to the development of cerebral oedema partly because clinicians do not have good data to predict the extent of deficits of sodium, potassium and water. However, there is a simple rule of thumb, formulated by Katz, which may help to calculate these deficits and pr...

    Show More
  • Kasabach-Merritt syndrome and interferon alpha: still a controversial issue.
    Paolo Biban

    Dear Editor

    We read with interest the paper by Akyuz and colleagues,[1] which described a 2 year old patient with a Kasabach-Merritt syndrome (KMS) secondary to an infiltrating angiolipoma, who was successfully treated with interferon alpha 2a (IFN-alpha).

    Although the case presents some points of interest, such as the previously unreported association of a KMS with a lipomatous tumor and the potential effec...

    Show More
  • Preventing sleep problems: can more be done ?
    Dr Srinivas S Gada

    Dear Editor

    I read this article with much interest. I commend the authors on identifying a new risk factor which should help in preventing sleep problems in at-risk infants.[1]

    However, I would like to point out that the 'three step behavioural programme' used in the study [1] does not include one measure which has been shown to be successful i.e,'effectiveness of sleep routine in the prevention of sleep...

    Show More

Pages